Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 32.98% is 660% above its 5-year average of -5.89%, around the middle of its 5-year range (-106.03%–95.19%).
2.63% above its 12-month average of 32.13%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 30.40%.
NET PROFIT MARGIN
32.98%
NET PROFIT MARGIN AVG TTM
32.13%
NET PROFIT MARGIN AVG 3Y
29.53%
NET PROFIT MARGIN AVG 5Y
-5.89%
NET PROFIT MARGIN AVG 10Y
-118.56%
NET PROFIT MARGIN AVG 15Y
-164.27%
NET PROFIT MARGIN AVG 20Y
-118.25%
CURRENT VS TTM AVG
+2.63%
CURRENT VS 3Y AVG
+11.70%
CURRENT VS 5Y AVG
+659.83%
CURRENT VS 10Y AVG
+127.82%
CURRENT VS 15Y AVG
+120.08%
CURRENT VS 20Y AVG
+127.89%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ADMA Biologics, Inc.
Market Cap
$2.36B
Net Profit Margin
32.98%
TTM Avg
32.13%
3Y Avg
29.53%
5Y Avg
-5.89%
Market Cap
$2.31B
Net Profit Margin
18.88%
TTM Avg
19.31%
3Y Avg
25.55%
5Y Avg
15.07%
Market Cap
$2.43B
Net Profit Margin
-0.74%
TTM Avg
-3.79%
3Y Avg
-13.87%
5Y Avg
-19.28%
Market Cap
$2.45B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.53B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.17B
Net Profit Margin
-268385.71%
TTM Avg
-9751.05%
3Y Avg
-6580.61%
5Y Avg
-4774.06%
Market Cap
$2.13B
Net Profit Margin
7.13%
TTM Avg
6.55%
3Y Avg
5.96%
5Y Avg
5.57%
Market Cap
$2.76B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
Market Cap
$2.07B
Net Profit Margin
-40.90%
TTM Avg
5.22%
3Y Avg
-37.29%
5Y Avg
-215.44%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ADMA Biologics, Inc. (ADMA) | $2.36B | 32.98% | 32.13% | 29.53% | -5.89% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.31B | 18.88% | 19.31% | 25.55% | 15.07% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | -0.74% | -3.79% | -13.87% | -19.28% |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | 0.00% | 0.00% | 0.00% | 0.00% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.53B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | -268385.71% | -9751.05% | -6580.61% | -4774.06% |
| Addus HomeCare Corporation (ADUS)vs › | $2.13B | 7.13% | 6.55% | 5.96% | 5.57% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | -54.75% | -325.19% | -290.00% | -135445.82% |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.07B | -40.90% | 5.22% | -37.29% | -215.44% |
| Alvotech (ALVO)vs › | $2.05B | -36.51% | -21.30% | -316.14% | -299.31% |
Operating Margin
42.3%
Net Profit Margin
33.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 30.40% |
| 2026-03-31 | 39.59% |
| 2025-12-31 | 35.48% |
| 2025-09-30 | 27.14% |
| 2025-06-30 | 28.05% |
| 2025-03-31 | 23.44% |
| 2024-12-31 | 95.19% |
| 2024-09-30 | 29.96% |
| 2024-06-30 | 29.91% |
| 2024-03-31 | 21.75% |
| 2023-12-31 | -23.88% |
| 2023-09-30 | 3.81% |
| 2023-06-30 | -10.60% |
| 2023-03-31 | -11.93% |
| 2022-12-31 | -24.47% |
| 2022-09-30 | -36.26% |
| 2022-06-30 | -40.60% |
| 2022-03-31 | -85.93% |
| 2021-12-31 | -63.11% |
| 2021-09-30 | -85.65% |
| 2021-06-30 | -106.03% |
| 2021-03-31 | -114.53% |
| 2020-12-31 | -139.06% |
| 2020-09-30 | -164.62% |
| 2020-06-30 | -259.11% |
| 2020-03-31 | -188.68% |
| 2019-12-31 | -87.74% |
| 2019-09-30 | -158.37% |
| 2019-06-30 | -201.37% |
| 2019-03-31 | -370.35% |
| 2018-12-31 | -444.68% |
| 2018-09-30 | -357.79% |
| 2018-06-30 | -316.71% |
| 2018-03-31 | -440.92% |
| 2017-12-31 | -108.16% |
| 2017-09-30 | -321.45% |
| 2017-06-30 | -265.83% |
| 2017-03-31 | -248.66% |
| 2016-12-31 | -137.01% |
| 2016-09-30 | -147.43% |
| 2016-06-30 | -264.66% |
| 2016-03-31 | -217.17% |
| 2015-12-31 | -182.42% |
| 2015-09-30 | -275.45% |
| 2015-06-30 | -357.22% |
| 2015-03-31 | -239.87% |
| 2014-12-31 | -239.35% |
| 2014-09-30 | -247.79% |
| 2014-06-30 | -264.03% |
| 2014-03-31 | -378.32% |
| 2013-12-31 | -1108.69% |
| 2013-09-30 | -242.83% |
| 2013-06-30 | -658.64% |
| 2013-03-31 | -408.82% |
| 2012-12-31 | -430.27% |
| 2012-09-30 | -900.75% |
| 2012-06-30 | -524.44% |
| 2012-03-31 | -13575.32% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
